Summary
To evaluate the effect of prednisone and triple treatment (sodium fluoride, calcium, and vitamin D) on trabecular and cortical bone serial bone mineral content (BMC) measurements were made at a metaphyseal (BMCD) and diaphyseal (BMCP) site on the forearm on 31 consecutive and previously bone-healthy patients scheduled for at least 24 weeks high-dose prednisone treatment. The patients were randomized into two further treatment groups: group I (n=16) received prednisone plus triple treatment and group II (n=15) received only prednisone. The two groups were similar with regard to age, sex, prednisone dose, and initial BMC. During 24 weeks treatment, BMCD (partially representing trabecular bone) and BMCP (mainly representing cortical bone) fell significantly and similarly, demonstrating that there is no preventive effect on bone mineral loss on the triple regimen. The BMC fall after 12 weeks was significantly more pronounced for metaphyseal (partially trabecular) than for diaphyseal (cortical) bone, whereas the values did not differ significantly after 24 weeks; this indicates a greater sensitivity to the hormone treatment of trabecular bone. In the entire group, the fall in BMC correlated positively with individual prednisone dose, significant at the diaphyseal site (r=0.39,P<0.05), but not at the metaphyseal site (r=0.31, P=0.08). It is concluded that corticosteroid-induced osteopenia is a diffuse bone disease which affects trabecular as well as cortical bone, suggesting that BMC measured on the forearm reflects changes in bone mineral at other locations.
Similar content being viewed by others
References
Jowsey J, Riggs BL (1970) Bone formation in hypercortisolism. Acta Endocrinol (Kbh) 63:21–28
Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J. Clin. Invest. 64:655–665
Frost HM, Villaneuva AR (1961) Human osteoblastic activity. III. The effect of cortisone on lamellar osteoblastic activity. Henry Ford Hosp Med Bull 9:97–99
Peck WA, Brant J, Miller I (1957) Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cellin vitro. Proc Natl Acad Sci USA 57:1599–1606
Melsen F (1978) Histomorphometric analysis of iliac bone in normal and pathological conditions. Thesis. Aarhus, Denmark
Christiansen C, Rødbro P (1977) Long-term reproducibility of bone mineral content measurements. Scand J Clin Lab Invest 37:321–323
Hahn TJ, Boisseau VC, Avioli LV (1974) Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab 39:274–282
Melsen F, Nielsen HE, Christensen P, Mosekilde Li, Mosekilde Le (1978) Some relations between photonabsorptiometric and histomorphometric measurements of bone mass on the forearm. In: Mazess RB (ed)Proceedings from Fourth International Conference on Bone Measurement, Publication 80-1978, United States Department of Health and Human Services, pp 45–50
Schlenker RA (1979) Percentages of cortical and trabecular bone mineral mass in the radius and ulna. Am J Roentgenol 126:1309–1312
Jowsey J, Riggs BL, Kelly PJ, Hoffman DL (1972) Effect of combined therapy with sodium fluoride, vitamin D, and calcium in osteoporosis. Am J Med 53:43–49
Christiansen C, Rødbro P (1975) Estimation of total body calcium from the bone mineral content of the forearm. Scand J Clin Lab Invest 35:425–431
Christiansen C, Rødbro P (1975) Bone mineral content and estimated total body calcium in normal adults. Scand J Clin Lab Invest 35:433–439
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rickers, H., Deding, A., Christiansen, C. et al. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int 36, 269–273 (1984). https://doi.org/10.1007/BF02405329
Issue Date:
DOI: https://doi.org/10.1007/BF02405329